Chief R&D Officer
Wed, Jul 6, 2022
Jul 6
exercised or converted securities in FATE
2,000 shares @ $4.84
Increased holdings by +1.10%
Net across this filing: 0.00% (+0 shares)
Option Exercise
Sale tied to a same-time option exercise
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).